Package 33342-440-07

Brand: abacavir and lamivudine

Generic: abacavir and lamivudine
NDC Package

Package Facts

Identity

Package NDC 33342-440-07
Digits Only 3334244007
Product NDC 33342-440
Description

30 TABLET, FILM COATED in 1 BOTTLE (33342-440-07)

Marketing

Marketing Status
Marketed Since 2024-12-20
Brand abacavir and lamivudine
Generic abacavir and lamivudine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "42b22ad0-4838-43fd-9bf7-f22dafc7c352", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "upc": ["0333342440075"], "unii": ["J220T4J9Q2", "2T8Q726O95"], "rxcui": ["602393"], "spl_set_id": ["d36624c8-d773-4f99-81fc-433fae17feb3"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (33342-440-07)", "package_ndc": "33342-440-07", "marketing_start_date": "20241220"}, {"sample": false, "description": "5 BLISTER PACK in 1 CARTON (33342-440-14)  / 6 TABLET, FILM COATED in 1 BLISTER PACK (33342-440-02)", "package_ndc": "33342-440-14", "marketing_start_date": "20241220"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (33342-440-98)  / 6 TABLET, FILM COATED in 1 BLISTER PACK (33342-440-02)", "package_ndc": "33342-440-98", "marketing_start_date": "20241220"}], "brand_name": "Abacavir and Lamivudine", "product_id": "33342-440_42b22ad0-4838-43fd-9bf7-f22dafc7c352", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 1A1 Inhibitors [MoA]", "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "33342-440", "generic_name": "Abacavir and Lamivudine", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abacavir and Lamivudine", "active_ingredients": [{"name": "ABACAVIR SULFATE", "strength": "600 mg/1"}, {"name": "LAMIVUDINE", "strength": "300 mg/1"}], "application_number": "ANDA212663", "marketing_category": "ANDA", "marketing_start_date": "20241220", "listing_expiration_date": "20261231"}